- Home
- OST vs IOVA Comparison
OST vs IOVA Comparison
Compare OST & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OST
- IOVA
- Stock Information
- Founded
- OST 2010
- IOVA 2007
- Country
- OST China
- IOVA United States
- Employees
- OST N/A
- IOVA N/A
- Industry
- OST Industrial Machinery/Components
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OST Technology
- IOVA Health Care
- Exchange
- OST Nasdaq
- IOVA Nasdaq
- Market Cap
- OST 601.6M
- IOVA 771.4M
- IPO Year
- OST 2022
- IOVA N/A
- Fundamental
- Price
- OST $0.13
- IOVA $1.79
- Analyst Decision
- OST
- IOVA Buy
- Analyst Count
- OST 0
- IOVA 10
- Target Price
- OST N/A
- IOVA $12.22
- AVG Volume (30 Days)
- OST 23.2M
- IOVA 11.8M
- Earning Date
- OST 08-25-2025
- IOVA 08-07-2025
- Dividend Yield
- OST N/A
- IOVA N/A
- EPS Growth
- OST N/A
- IOVA N/A
- EPS
- OST N/A
- IOVA N/A
- Revenue
- OST $38,333,251.00
- IOVA $212,679,000.00
- Revenue This Year
- OST N/A
- IOVA $86.62
- Revenue Next Year
- OST N/A
- IOVA $69.95
- P/E Ratio
- OST N/A
- IOVA N/A
- Revenue Growth
- OST N/A
- IOVA 11070.12
- 52 Week Low
- OST $0.13
- IOVA $1.64
- 52 Week High
- OST $9.40
- IOVA $12.51
- Technical
- Relative Strength Index (RSI)
- OST 25.45
- IOVA 36.19
- Support Level
- OST $6.07
- IOVA $1.66
- Resistance Level
- OST $6.91
- IOVA $1.77
- Average True Range (ATR)
- OST 1.14
- IOVA 0.13
- MACD
- OST -0.38
- IOVA -0.01
- Stochastic Oscillator
- OST 0.45
- IOVA 4.32
About OST Ostin Technology Group Co. Ltd.
Ostin Technology Group Co Ltd is a supplier of display modules and polarizers in China. It designs, develops, and manufactures TFT-LCD modules in a wide range of sizes and customized sizes according to the specifications of its customers. Its display modules are mainly used in consumer electronics, commercial LCD displays, and automotive displays. The company also manufactures polarizers used in the TFT-LCD display modules and is in the process of developing polarizers for the OLED display panel. Geographically, the company generates revenue from Hong Kong, Taiwan, and Mainland China which is its key revenue generating market.
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.